About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, October 27th, 2017

The QualityStocks
Daily Stock List


Prism Technologies Group, Inc. (PRZM)

MarketWatch, Zacks, Wall Street Journal, TradingView, and InvestorsHub reported on Prism Technologies Group, Inc. (PRZM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 1995, Prism Technologies Group, Inc. is an intellectual property (IP) licensing and technology research & development (R&D) company. The Company, via its wholly-owned subsidiaries, owns a patent portfolio consisting of nine patent families incorporating 61 issued and six pending patents in the Computer & Network Security, Semiconductors, and Medical Technology space.

Prism Technologies Group is the parent company of Prism Technologies, LLC, which is a Nebraska Limited Liability Company (LLC) headquartered in Omaha, Nebraska. Prism Technologies Group is headquartered in Folsom, California.

Prism Technologies Group licenses and enforces a portfolio of patents relating to its technologies. The Company continues to develop and patent new technologies. Its commitment is to continuing R&D efforts in several fields. The Company’s mission is to continue to develop and invent new technologies in computer and network security, wearable computing, transaction processing, and healthcare to expedite time to market opportunities for its clients.

In May 2017, Prism Technologies Group announced that the Court of Appeals for the Federal Circuit rejected a request by Sprint Spectrum LP d/b/a Sprint PCS for a rehearing of Sprint’s appeal of the patent infringement verdict, in favor of Prism Technologies Group subsidiary, Prism Technologies LLC.

In June 2015, a jury in the United States District Court for the District of Nebraska found that the accused Sprint network systems and methods infringe many claims of U.S. Patent Nos. 8,387,155 and 8,127,345, and Prism LLC was awarded trial damages of $30 million. Prism LLC was also awarded $2 million in prejudgment interest. It will be entitled to post-judgment interest in an amount to be determined.

The suit against Sprint is the second of five patent infringement lawsuits filed by Prism LLC against wireless carriers in U.S. District Court for the District of Nebraska.

Last week, Prism Technologies Group announced that it entered into an Asset Purchase Agreement with Amorphous Technologies International (ATI). This Agreement is to acquire certain intellectual property (IP) assets related to unique uses for amorphous metals. After the close of the transaction, Prism will commercialize the acquired IP assets to create new amorphous metal technology offerings for the consumer electronics, automotive, industrial, and other business sectors.

ATI is a leader in development of inventive amorphous alloy solutions founded on proprietary materials technology. Its solutions deliver value through removing the limits of existing materials technology that result in high costs throughout the lifecycle of a product.

Prism Technologies Group, Inc. (PRZM), closed Friday's trading session at $0.095, up 35.71%, on 21,100 volume with 4 trades. The average volume for the last 60 days is 51,618 and the stock's 52-week low/high is $0.0301/$1.06.

Sunvalley Solar, Inc. (SSOL)

Wallstreetlivechat, PennyStockPros, The Stock Scout, Penny Stock Rumble, Stockhunter.us, PennyStockClub, OurHotStockPicks, PennyStocks24, Fast Moving Stocks, VIP STOCK ALERTS, and FeedBlitz reported previously on Sunvalley Solar, Inc. (SSOL), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Sunvalley Solar, Inc., by way of its subsidiary, Sunvalley Solar Tech, Inc., operates as a solar power technology and system integration company in the State of California. The Company centers on solar systems design and installation, solar technology research and development (R&D), and solar equipment manufacturing and distribution areas. Established in 2007, Sunvalley Solar is headquartered in in Walnut, California.

Sunvalley Solar acquired Rayco Energy, Inc. in 2016. Rayco Energy is an established northern California company. It specializes in providing cost-saving and efficient energy solutions to local communities and business units. This includes LED lighting, Solar Thermal, as well as Solar Electricity.

Rayco Energy combines energy efficiency measures with renewable energy sources. It services the multi-family sector (Apartments, Homeowner Associations (HOA)) and small-sized commercial projects.

Sunvalley Solar’s business development strategy is to develop the Company as the end-to-end solar energy solution provider for solar power equipment dealers, solar power system installers, and solar power energy end users.

The Company provides turnkey solar system solutions. These include designing, building, operating, monitoring, and maintaining solar power systems for owners, builders, and architecture firms. Its R&D team comprises PhDs in Optoelectronics. The team specializes in photovoltaic panel technologies (coating and focusing).

In addition, the Company’s focus is in the area of National Solar Technical Support and a Service Center. Sunvalley Solar serves small private residences and large commercial solar power users.

The Company’s R&D team’s projects include 975 kW commercial solar power systems for distribution warehouses and manufacturing companies. Furthermore, projects include 1 MW commercial solar power systems for agriculture farms and cold storage facilities.

Its R&D is presently focusing on developing new coating technology to increase the efficiency of PV panels; developing new focusing technology to reduce the size of silicon cells and reduce the silicon cost per watt; developing solar PV application technology to decrease system level cost; and developing new solar parts – Micro-inverters.

Sunvalley Solar has its patented technology – Networked Solar Panels and Related Methods. It has patented the technology "Networked Solar Panels and Related Methods" (USPTO 12/198,076). This technology enables the solar power system operator to monitor the grid status, and manage and control the output from each panel, each subsystem, and the system as a whole.

Sunvalley Solar, Inc. (SSOL), closed Friday's trading session at $0.0378, up 0.27%, on 432 volume with 2 trades. The average volume for the last 60 days is 5,041 and the stock's 52-week low/high is $0.0351/$0.1588.

Drone USA, Inc. (DRUS)

Stock News Now, OTC Markets, InvestorsHub, Stock Daily Review, 4-Traders, and Stockhouse reported on Drone USA, Inc. (DRUS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Drone USA, Inc. is a developer, manufacturer, and distributor of low altitude drones and related technologies. The OTCQB-listed Company’s main target markets include U.S. police, firemen, as well as the U.S. Government. Drone USA designs and builds high quality drones, training, insurance, replacement parts and anything a customer requires to make sure their missions are successful. All the Company’s products will be manufactured and assembled in the U.S. Drone USA is based in West Haven, Connecticut.

The services the Company offers include Real Estate Photography for Advertisement; Utility Inspection; and Construction Inspection & Photo/Video Marketing. Services also include Precision Agriculture; Search & Rescue Assistance; and Fire Hot Spot Location. All of Drone USA’s drones operate with closed encrypted software. This is for national security purposes.

Howco Distributing Co. (Vancouver Washington) is a subsidiary of Drone USA. Howco Distributing is Drone USA’s manufacturing supply chain segment. Howco Distributing is a premier supplier of spare and replacement parts to the United States Federal Government and commercial customers internationally. Howco is an authorized provider for hundreds of manufacturers and original equipment manufacturers (OEM’s).

Last month, Drone USA announced that it demonstrated its Police Cyclops and Shadow Drones on Jennings Beach in Fairfield, Connecticut this past summer to a number of Connecticut law enforcement agencies. The Company also announced in September that Dr. Len Harac is joining the Drone USA Board of Directors.

Mr. Michael Bannon, Chief Executive Officer of Drone USA, said in September, “ … On the first mission, we sent Cyclops, our fixed wing drone, equipped with a high resolution zoom camera, to a small Island where the Fairfield Police said that boaters often get into trouble. Then our Cyclops ventured to an area where a thirty-six foot yacht sank the weekend before. Cyclops videoed the wreckage. Then it followed a path along the beach and safely landed in area where several Connecticut police departments where watching. On the second mission our Shadow drone equipped with a thermal camera scanned the swimming areas along the beach…”

Drone USA recently announced that it is working on three profitable growth strategies. These are Police & U.S. Government drone sales; growing Howco Distributing’s product line and reach; and acquiring companies that broaden Drone USA’s product and customer base.

Pertaining to its Howco growth strategy, Drone USA is working to expand its reach through opening up two new distribution centers. This includes one in the southeast, possibly Louisiana, and the other in Connecticut or New Jersey.

Drone USA, Inc. (DRUS), closed Friday's trading session at $0.1998, down 0.05%, on 9,000 volume with 3 trades. The average volume for the last 60 days is 2,650 and the stock's 52-week low/high is $0.1202/$0.95.

Airborne Wireless Network (ABWN)

PennyStockLocks, Penny Stock 101, StockRockandRoll, Penny Stock Craze, Penny Stocks Finder, Stock Commander, Profitable Trader Authority, Damn Good Penny Picks, Penny Picks, Epic Stock Picks, Beacon Equity Research, Broad Street, OTCBB Journal, and SuperStockTips reported earlier on Airborne Wireless Network (ABWN), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Airborne Wireless Network’s plan is to be a high-speed broadband internet pipeline to improve coverage connectivity now lacking. Its intention is to create a high-speed broadband airborne wireless network through linking commercial aircraft in flight. Each aircraft participating in the network will act as an airborne repeater or router, sending and receiving broadband signals from one aircraft to the next. This will create a digital superhighway in the sky. Airborne Wireless Network has its corporate office in Simi Valley, California.

Regarding its Wholesale Carrier Network, the Company’s plan is to use commercial aircraft as “mini-satellites”. Airborne Wireless Network’s primary target customer-base will be international data and communications service providers. Its system is to operate in a safe and controlled environment, typically between 20,000 and 40,000 feet (6,000-12,000 m).

The Company does not intend to provide retail customer coverage to end users. It will act as a wholesale carrier with target customers. It believes that its network, upon development, should provide low cost, high-speed connectivity to rural areas, island nations, ships at sea, oil platforms, plus connectivity to commercial and private aircraft in flight.

Airborne Wireless Network is developing a fully meshed network. In a fully meshed network, signals come in from numerous directions. The system will route signals around any obstructions. Fundamentally, it is a virtual airborne Worldwide Web. Because it is a meshed network, it is alike to a web where all nodes are connected through multiple links.

Airborne Wireless Network has completed its acquisition of Patent Number US 6,285,878 B1 and the Trademark "Infinitus Super Highway". These acquired assets serve as a blueprint and road map for it to develop its "Airborne Wireless Network". In November of 2016, the Company announced it received an FAA Project Number for its Supplemental Type Certificate (STC) application to install a Broadband Transceiver System on Boeing 757-200 aircraft.

This past August, Airborne Wireless Network announced that Marius de Mos, the Company's Vice President of Technical Affairs and Development, as inventor, filed with the USTPO on July 25, 2017, a new non-provisional patent application, number 15/658,761. The patent describes a "method of synchronizing laser-links between aircraft." Airborne Wireless Network will be using this method as a roadmap to attempt to exponentially boost data transfer speeds for its considered Infinitus Super Highway.

On August 11, 2017, Airborne Wireless Network entered into a design and manufacturing services agreement with ViaLight Communications, GmbH. ViaLight Communications is a developer of laser based high-speed communication products. ViaLight has been engaged by Airborne Wireless Network to develop, design, test, and manufacture a custom hybrid synchronized laser based communication system to link neighboring aircraft and/or ground stations on Airborne's Infinitus Super Highway.

Airborne Wireless Network (ABWN), closed Friday's trading session at $1.37, up 14.17%, on 197,567 volume with 257 trades. The average volume for the last 60 days is 105,626 and the stock's 52-week low/high is $0.705/$4.07.

ImmuDyne, Inc. (IMMD)

Buzz Stocks, Planet Penny Stocks,PennyStocks24, Penny Pick Finders, SecretStockPromo, PennyStockProphet, and StockOnion reported earlier on ImmuDyne, Inc. (IMMD), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, ImmuDyne, Inc. is a health, wellness, and skincare company commercializing a portfolio of proprietary topical and orally delivered products. These rely on ImmuDyne’s patented and pure Yeast Beta Glucan ingredients. The Company has developed proprietary topical and oral products and a proprietary natural delivery technology with numerous new market opportunities. ImmuDyne is a leader in the development and online marketing of OTC (Over the Counter) health and wellness products addressing significant unmet needs.

Immudyne PR is a majority-owned subsidiary of ImmuDyne, Inc. ImmuDyne has offices in Mt. Kisco, New York; Huntington Beach, California; San Juan, Puerto Rico; and Florence, Kentucky.

The Company also manufactures and sells yeast beta-1,3/1,6 glucan for oral and topical uses. ImmuDyne’s strategy is to create new market spaces within the wellness industry through the launch of clinically researched, doctor recommended immune support products and services. Via a highly complex, proprietary process that uses best-in-class technology, ImmuDyne can extract highly purified beta-1,3/1,6-D-glucan from the cell walls of Saccaharomyces cerevisiae.

The Company says that it is well-established in the scientific community that beta-glucans are strong activators of the innate immune response. Recent studies indicate that yeast beta-1,3/1,6-D-glucans can also activate adaptive immune responses.

Immudyne PR is the digital marketing arm of Immudyne and is now focusing on marketing products for thicker and fuller hair (Shapiro MD) and a skincare line containing Immudyne’s proprietary Yeast Beta Glucan ingredient (Inate MD). The InateMD product line contains an ultra-pure Yeast Beta Glucan compound proven to support the human immune system.

ImmuDyne has launched nationally its patented Shapiro MD product line. The Shapiro MD product line is the result of 15 years of research and development by dermatologists Dr. Steven Shapiro and Dr. Michael Borenstein.  It is protected by two U.S. patents.

Earlier this month, ImmuDyne announced that Mr. Robert Kalkstein will be joining the Company as Chief Financial Officer (CFO). Mr. Kalkstein will be responsible for ensuring the finance organization can support ImmuDyne’s aggressive growth plans currently and in the future.

Mr. Kalkstein has greater than 10 years of experience in the accounting, finance, SEC compliance, and operations areas. He previously held positions at Peerless System Corp., Jefferies & Co., and PricewaterhouseCoopers.

In addition, this month, ImmuDyne announced its unaudited financial results for Q3 of 2017. The Company and its ImmuDyne PR report that they collectively attained record Gross Revenue of $2.077M in Q3. The Company anticipates continued quarterly revenue growth from its existing brands and also from new brands launching over the next two quarters. ImmuDyne’s Cash on hand was roughly $600,000, as of September 30, 2017.

ImmuDyne, Inc. (IMMD), closed Friday's trading session at $0.4202, down 8.65%, on 4,250 volume with 4 trades. The average volume for the last 60 days is 29,895 and the stock's 52-week low/high is $0.21/$0.95.

Acura Pharmaceuticals, Inc. (ACUR)

PennyStocks24, Penny Stock Rumble, The Street, BestOtc, BUYINS.NET, CRWEFinance, CRWEWallStreet, PennyOmega, PennyToBuck StreetInsider, Marketbeat, SmarTrend Newsletters, Wall Street Resources, StockHotTips, and DrStockPick reported previously on Acura Pharmaceuticals, Inc. (ACUR), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company innovating abuse deterrent drugs. The Company engages in the research, development, and commercialization of product candidates intended to address medication abuse and misuse, using its proprietary AVERSION®, IMPEDE®, and LIMITx™, Technologies. Acura Pharmaceuticals has its corporate office in Palatine, Illinois.

AVERSION® Technology is a patented composition of commonly used active and inactive pharmaceutical ingredients providing abuse deterrent features and benefits for orally administered pharmaceutical drug products. The intention of AVERSION® Technology opioid analgesic product candidates is to provide effective relief from pain. This is while discouraging common methods of pharmaceutical product misuse and abuse.

The IMPEDE® Technology platform is an advanced polymer matrix. It is used in NEXAFED®, Acura Pharmaceuticals’ pseudoephedrine (PSE) tablet product, to limit or disrupt the extraction of PSE from tablets for conversion into the illicit drug methamphetamine.

The intention of Acura’s LIMITX™ Technology is to address an oral Excessive Tablet Abuse (ETA) or accidental consumption of multiple tablets, and also provide a margin of safety during accidental over-ingestion of tablets. Furthermore, LIMITX™ is expected to exhibit barriers to abuse by snorting and injection. LTX-04 is the Company’s lead development candidate employing its novel LIMITx™ technology.

OXAYDO® (oxycodone HCl immediate-release tablets), which incorporates the AVERSION Technology, is Food and Drug Administration (FDA) approved and marketed in the U.S. by Acura Pharmaceuticals’ partner Egalet Corp. NEXAFED® and NEXAFED® Sinus are pseudoephedrine containing products that uses the IMPEDE Technology. They are marketed in the U.S. by Acura’s partner MainPointe Pharmaceuticals.

This month, Acura Pharmaceuticals announced that topline results from clinical study AP-LTX-300 (Study 300) for its LIMITx™ oral abuse deterrent drug LTX-03 demonstrated rapid release of drug from the micro-particle formulation providing expected therapeutic drug levels in the bloodstream for a single dose. LTX-03 is a combination of hydrocodone bitartrate and acetaminophen.

In earlier studies, Acura demonstrated the LIMITx micro-particles decreased peak blood concentrations of drug by 50 to 65 percent when multiple tablets are ingested. Because of erratic release of drug from the over-encapsulated tablets used in Study 300, Acura could not reliably identify the precise buffer level for a single LIMITx tablet. The Company’s plan is to execute another dose ranging study without using over-encapsulation. It expects to complete this next study in Q1 of 2018.

Study 300 was a parallel design pharmacokinetic study testing LIMITx formulation LTX-03 in 56 healthy adult subjects divided evenly into 7 groups. One group swallowed a single Norco® tablet, the marketed comparator or reference drug. The remaining 6 groups swallowed a single LIMITx micro-particle tablet with increasing buffering amounts beginning with no buffer to ascertain the appropriate single tablet buffer amount.

All 56 subjects completed the study. The doses were generally well tolerated with no serious adverse events.

Acura Pharmaceuticals, Inc. (ACUR), closed Friday's trading session at $0.45, even for the day, on 20,085 volume with 19 trades. The average volume for the last 60 days is 12,020 and the stock's 52-week low/high is $0.4002/$1.40.

Nevada Energy Metals, Inc. (SSMLF)

ProfitableTrading, InvestorIntel, and SeeThruEquityResearch reported on Nevada Energy Metals, Inc. (SSMLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Nevada Energy Metals, Inc. is an exploration company listed on the OTC Markets’ OTCQB. Its chief exploration emphasis is directed at Lithium brine targets located in Nevada. The Company formerly went by the name Southern Sun Minerals, Inc. It changed its corporate name to Nevada Energy Metals, Inc. in February 2016. Nevada Energy Metals has its headquarters in Vancouver, British Columbia.

The Company completed the acquisition of 100 percent ownership in the San Emidio Project (155 claims, 3,100 acres/1,255 hectares) near Empire, Washoe County, Nevada; and the Dixie Valley Project comprising 911 claims encompassing 73.6 square kilometers/28.4 square miles (7,363 hectares/18,194 acres) of salt marsh playa.

The lithium deposit model for Dixie Valley is a Clayton Valley-style brine deposit. Dixie Valley is in west central Nevada, about 160 km east northeast of Reno.

The Company also completed a 70/30 farm-out option Joint Venture (JV) on 77 claims in Clayton Valley, roughly 250m from the Rockwood Lithium mine, the only brine based Lithium producer in North America. In addition, Nevada Energy Metals completed the acquisition of 100 percent of the Teels Marsh West project (100 claims encompassing 2000 acres/809 hectares) at Teels Marsh, Mineral County, Nevada.

Nevada Energy Metals has acquired 160 placer claims, with an area of 3,200 acres/1,295 hectares, situated in northern Big Smokey Valley, Township 13N., Range 43E, Nye County, Nevada. It acquired a 100 percent interest in the property, free of royalty payments.

The Alkali Lake Project in Esmeralda County is a 60 percent earn in option agreement from Dajin Resources Corp. At this project, near surface lithium values have been confirmed.

In October 2016, Nevada Energy Metals announced that highly encouraging results were received from a sampling program designed to test for lithium values in surface soils and/or playa evaporates at the San Emidio Desert Project. A total of 172 samples were collected.

Lithium values ranged from 30.3 to a high of 600 ppm (30 mg/L to 600mg/L) with a median value of 215 ppm (215mg/L). Thirty-two samples were above 300 ppm (300mg/L) and 13 were over 400 ppm (400/mg/L).

Recently, Nevada Energy Metals announced that it amended two Option Agreements with LiCo Energy Metals, Inc. Regarding Dixie Valley in Churchill County, Nevada, further to an Option Agreement dated July 14, 2016 with LiCo where LiCo may acquire up to a 100 percent interest in the Dixie Valley Property, the parties entered into an Amending Agreement to amend the next Option share payment of 2,000,000 shares, which was due to be paid to Nevada Energy Metals on the second anniversary of the Option Agreement. It will now be paid upon signing of the Amending Agreement; along with other work and development commitments.

Concerning Black Rock Desert, Washoe County, Nevada, further to an Option Agreement dated November 10, 2016 with LiCo, where LiCo may acquire up to a 70 percent interest in the Dixie Valley Property, the parties entered into an Amending Agreement to amend the Agreement so that LiCo may now earn a 100 percent interest in the Property.

Nevada Energy Metals, Inc. (SSMLF), closed Friday's trading session at $0.0214, even for the day. The average volume for the last 60 days is 69,530 and the stock's 52-week low/high is $0.0104/$0.1027.


The QualityStocks
Company Corner


Tapinator, Inc. (TAPM)

The QualityStocks Daily Newsletter would like to spotlight Tapinator, Inc. (TAPM). Today, Tapinator, Inc. closed trading at $0.1725, off by 4.11%, on 161,080 volume with 44 trades. The stock’s average daily volume over the past 60 days is 73,868 and its 52-week low/high is $0.0711/$0.2419.

Tapinator, Inc. (TAPM), a leading developer and publisher of mobile games on the iOS, Google Play and Amazon platforms, announces that it has engaged the corporate communications expertise of NetworkNewsWire ("NNW").

Tapinator, Inc. (TAPM) is a developer and publisher of mobile games on the iOS, Google Play and Amazon platforms. The Company's portfolio includes over 300 mobile gaming titles generating hundreds of thousands of daily player downloads that provide predictable and attractive returns through the sale of branded advertisements and consumer app store transactions. Tapinator, based in New York and with product development teams located throughout the world, was founded in 2013 by a visionary team that has been building mobile games and applications since 2007 and has achieved multiple successful exits.

Tapinator's business strategy includes the creation of a select number of best-in-class Full-Featured Games, such as ROCKY™ and Solitaire Dash, which provide game players with more in-depth, unique content that supports long-term retention and generates higher investment returns. The Full-Featured Games model creates the potential for sustainable $100+ million franchise-type games that have product lifespans of at least five years. Tapinator uses a proprietary set of dynamic development and marketing processes factored upon gaming category, estimated player retention and projected player profitability.

Recent successful launches of two new Full-Featured titles – Big Sport Fishing 2017 and Dice Mage 2 – were recognized on the Apple iOS platform as "New Games We Love." During the game's first seven days after global release, Big Sport Fishing 2017 received well over 520,000 player downloads. Four new titles, ColorFill, Divide & Conquer, Shadowborne and Fusion Heroes, are in the pipeline for release in Q4 2017 and Q1 2018 as well. The formula for these game combines proven gameplay elements with best-in-class monetization systems, supplemented by Tapinator's strong creative team of developers, strategists and product specialists. The company's Rapid-Launch Games division also saw increasing player interest recently with the launch of Fidget Spinner Superhero and Scary Shark Evolution 3D.

Tapinator's diversified revenue sources includes 54 percent from advertising placed within its mobile games and 46 percent from consumer app store purchases. The Company limits advertising placements to between game levels and also runs rewarded video ad units that are tied directly into the game's currency. Tapinator's portfolio includes more than 300 active titles, with no single game accounting for more than 25 percent of total revenues during the first half of 2017.

As Tapinator looks toward the future, opportunities in Virtual Reality (VR) and Augmented Reality (AR) show great promise. The company has released several prototype VR games to gather data before pursuing a more significant VR product. Recent market reports suggest that the VR industry will hit $30 billion by 2020 and the AR industry will surpass that with a projected $120 billion. Tapinator also plans to pursue publishing transactions that leverage its network, platform relationships and operational excellence. Significant opportunities for expanding Tapinator's gaming IP to new platforms such as Steam and leading messaging apps are also on the horizon. The company is targeting a 30+ percent annual bookings growth target for 2017-2019. Disclaimer

Tapinator, Inc. Blog

Tapinator, Inc. News:

Tapinator, Inc. (TAPM) Engages NetworkNewsWire for Corporate Communications Solutions

NetworkNewsWire Releases Exclusive Audio Interview with Tapinator, Inc. (TAPM)

Clowns to Haunt Mobile Phones for Halloween 2017 as Scary Clown: Halloween Night Goes Live on Google Play & Amazon App Store

InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.3221, off by 1.80%, on 320,049 volume with 214 trades. The stock’s average daily volume over the past 60 days is 514,652, and its 52-week low/high is $0.09/$0.72.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a client of NNW specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. The publication, titled, "Innovative Biotechnology Companies are Transforming Cannabis-based Medical Products," discusses some innovative biotech companies bringing new functions of CBD to light through advanced technology. To view the full publication, visit:

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

NetworkNewsWire Announces Publication Highlighting Innovations in Cannabis R&D

NetworkNewsWire Announces Publication Discussing Advanced Technology in Cannabinoid R&D

NetworkNewsWire Announces Publication on the Impact of Biosynthesis on Cannabinoid Pharmaceuticals

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.49, off by 5.77%, on 70,075 volume with 44 trades. The stock’s average daily volume over the past 60 days is 107,201 and its 52-week low/high is $0.3622/$2.75.

ChineseInvestors.com, Inc. (CIIX) has launched its daily video telecast on cryptocurrencies from the NYSE, “Bitcoin Multimillionaire,” by teaming with specialist broadcaster to the Chinese-speaking global community, Wall Street Multimedia, Inc. (WSM) (http://nnw.fm/NElH4).

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News:

ChineseInvestors.com, Inc. (CIIX) Launches New Daily Video Broadcast “Bitcoin Multimillionaire” By Teaming With Wall Street Multimedia, Inc.

ChineseInvestors.com, Inc. Launches Bitcoin Multimillionaire, the First Daily Video Cryptocurrency Newscast in the Chinese Language, With Plans to Launch a New Cryptocurrency Website Under the Domain 'newcoin168.com'

SeeThruEquity Issues Update on ChineseInvestors.com Inc. (OTCQB: CIIX)

AppSwarm, Inc. (SWRM)

The QualityStocks Daily Newsletter would like to spotlight AppSwarm, Inc. (SWRM). Today, AppSwarm, Inc. closed trading at $0.0109, up 13.54%, on 119,999 volume with 6 trades. The stock’s average daily volume over the past 60 days is 183,380 and its 52-week low/high is $0.002/$0.04.

AppSwarm, Inc. (SWRM) is a technology development and incubation acceleration company that partners up with developers through joint ventures, royalty agreements, marketing partnerships, and outright purchase agreements. Focusing on the ever-growing mobile applications market, the company provides all the resources needed for engagement, retention, virality and monetization.

The global games market generated approximately $100 billion in revenues in 2016, but large global game companies have made it extremely difficult for smaller developers to achieve success in the marketplace. As a result, many great ideas aren't monetized. AppSwarm solves this problem by providing the funding and critical business expertise needed to successfully launch and market new applications.

Business applications is another area of focus for the company. Targeting small to medium sized businesses, AppSwarm will be developing and acquiring mobile application tools and platforms that increase productivity and security via data encryption, cloud storage, content management and delivery, digital payments, automation, and customer loyalty marketing solutions. Recent acquisitions made so far represent only a small example of future planned initiatives to develop and market tools for the business community.

Regardless of the target market, AppSwarm can help developers accelerate the success of their app through funding, technology and marketing expertise, as well as a unique eco system that accelerates user acquisition. The company is able to assist at any state of development with completion of concept, market analysis, business and financial management, direct sales and marketing, social game development to ensure correct product application and expedient deployment with cost efficiency.

Ron Brewer, CEO of the company, has accumulated extensive leadership in the technology sector and brings valuable knowledge gained as a Director of Southbridge Advisory Group for nearly 20 years. Ron's C-level experience includes merger & acquisition and post-acquisition turnaround in both the private and small-cap public sector. John Rabbit, director of finance, is a seasoned business veteran that has worked with Fortune 500 firms and served in CEO, COO and CFO positions for firms ranking from $5 million to $300 million in annual revenues. John was directly involved in numerous acquisitions and served in executive capacities for several multinational subsidiaries.

With a well-suited management team, multiple synergistic revenue streams, and diversified growth strategy, AppSwarm is well positioned in a steadily growing industry with countless opportunities for capitalization. Disclaimer

AppSwarm, Inc. Blog

AppSwarm, Inc. News:

AppSwarm and SinglePoint Sign LOI to Conduct a Shared Roll-Out of Mobile Applications Specifically Geared to the Cannabis Industry

AppSwarm and SinglePoint Sign LOI to Launch Cannabis-Focused Applications

AppSwarm, Inc. Announces Joint Venture with Last-Mile Delivery Firm Estorerunner

RJD Green Inc. (RJDG)

The QualityStocks Daily Newsletter would like to spotlight RJD Green Inc. (RJDG). Today, RJD Green Inc. closed trading at $0.0089, up 5.95%, on 1,462,000 volume with 20 trades. The stock’s average daily volume over the past 60 days is 1,644,826, and its 52-week low/high is $0.0024/$0.029.

RJD Green Inc. (RJDG) is a holding company with a focus on acquiring and managing assets and companies in three divisions. These initial high-growth enterprise opportunities offer diversity in separate recession resistant markets. The division holdings include:

  • RJD Green Healthcare Services – provides services to reduce cost and enhance management and operational capabilities in the healthcare sector.
  • Earthlinc Environmental Services – provides green environmental services and technologies.
  • Silex Holdings – acquires specialty construction and industrial manufacturing assets.

RJD Green Healthcare Services, through its wholly owned subsidiary IOSOFT Inc., provides proprietary software and IT support for medical billing, healthcare claims adjudication, and electronic payments between healthcare payers and providers. IOSOFT's unique payment technologies and services or software can be integrated with existing systems of healthcare payers such as Blue Cross, Aetna, CIGNA and others. IOSOFT provides targeted offerings for healthcare providers, provider networks, physicians and hospitals, and clearinghouse companies.

Earthlinc Environmental Solutions was formed to bring forward green-applied technologies and offer environmental services with a focus on North America. The division's first acquisition, Animal Waste Management, is launching operations of a patented, fully developed technology for processing waste produced on commercial poultry and hog farms. Development of this technology was supported by the University of Arkansas and the Missouri Department of Natural Resources. This important technology improves the farm's productivity and is competitively priced with the current expense of handling waste removal at these sites.

The company's third division – Silex Holdings Inc. – was formed to acquire and manage high-growth assets and business enterprises in the industrial and construction specialty services sectors. With its first acquisition of Silex Interiors, a manufacturer, distributor and installer of counter tops, cabinets and related kitchen and bath products, the division is poised to expand into major national markets through internal expansion, acquisition and franchising. The company is modeled to operate a minimum of four corporately owned locations with 12 to 18 franchise locations nationwide.

RJD Green seeks to participate as owners, partners or in joint ventures in a wide range of business enterprises. The company's goal of creating a successful, enjoyable business enterprise for its company team and staff, along with its business partners and investors, is paired with the goal of maximizing the business potential of the enterprise by enhancing profits and the quality of the company. Disclaimer

RJD Green Inc. Company Blog

RJD Green Inc. News:

RJD Green Inc. Appoints Director

RJD Green Inc. Subsidiary, IOSOFT, Discusses Contracts Procured and Revenue Expectations

RJD Green Inc. Announces The Silex Holdings Division Contract Awarded as Preferred Vendor

Algae Dynamics Corp. (ADYNF)

The QualityStocks Daily Newsletter would like to spotlight Algae Dynamics Corp. (ADYNF). Today, Algae Dynamics Corp. closed trading at $0.08, even for the day. The stock’s average daily volume over the past 60 days is 12,097 and its 52-week low/high is $0.0001/$0.61.

Algae Dynamics Corp. (ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae.

The original core of the company's product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives to marijuana consumption will help support ongoing initiatives to create and market research-driven product formulations.

Although the company is publicly traded in the U.S., business is conducted in Canada with no exposure to U.S. federal regulation involving cannabis. The Canadian cannabis oil extraction marketplace is projected to grow from C$1 million in 2015 to C$1.7 billion in 2020, which is more than a 1,000-fold increase. With the Government of Canada indicating a target date for full legalization on or before July 2018, numerous opportunities for sales in extracts and oils will open up very soon.

Using Colorado as a comparable example, a study performed by Mackie Research Capital found that 45% of dried marijuana users in the state would eventually convert to marijuana extracts and oils. This is because most consumers taking cannabis for medical purposes are increasingly looking for delivery systems that do not involve smoking marijuana. The market's attractiveness can be further realized when considering that the Canada's licensed producer marketplace is far less competitive with 45 current licensed producers for the whole country vs. 624 licensed cultivators in Colorado.

Collaborating with prominent Canadian universities is a core part of the Algae Dynamics' plan to bolster cannabis extraction expertise, develop premium products and add to its portfolio of intellectual property. Through its agreements with the University of Waterloo and the University of Western Ontario, the company is focusing primarily on the use of extracts from cannabis oil and algae oil in the context of cancer as well as the development of new pharmacotherapies for mental health.

Near-term goals include expanding research and development work with existing and new Canadian universities, securing supply/service agreements with licensed producers, and submitting an application to Health Canada to become a licensed producer of medical marijuana and ultimately have a license to sell products derived from cannabinoids. Algae Dynamics also owns a proprietary technology for the cultivation of low cost, highly pure algae biomass, which will be developed as a vertical integration strategy in the future to support the need to source algae oil for research-driven product formulations. The management team leading these initiatives has nearly a century of beneficial experience spanning from management and process experience to successful fund raising and commercialization.

As part of its key objective to be the #1 research Canadian cannabis oil research-driven product formulator, the company has also formed a strong team of scientific and strategic advisors that complement ongoing R&D relationships and initiatives. Individuals who support the company's initiatives include Dr. Jonathan Blay PhD, FRSB, FIBMS, Csci, CBiol, who performs research and product development on cannabis oil and its constituents in the context of colorectum, pancreas, breast and prostate cancers; and Dr. Steven Laviolette, BSc, PhD, who performs research and product development on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia.

With such a strong foundation laid in the areas being pursued, Algae Dynamics is well positioned to execute on its carefully developed business plan to fast-track to revenue growth while having a longer-term strategy to build a sustainable enterprise-building opportunity in a rapidly expanding market. Disclaimer

Algae Dynamics Corp. Blog

Algae Dynamics Corp. News:

Algae Dynamics Corp Enters Into a Letter of Intent with Bonify to Produce Unique Cannabis Oil Products; Accelerates Go-to-Market Strategy

NetworkNewsWire Releases Exclusive Audio Interview with Algae Dynamics Corp. (ADYNF)

Algae Dynamics Corp. (ADYNF) Engages NetworkNewsWire for Corporate Communications Solutions

HighCom Global Security, Inc. (HCGS)

The QualityStocks Daily Newsletter would like to spotlight HighCom Global Security, Inc. (HCGS). Today, HighCom Global Security, Inc. closed trading at $0.02, even for the day. The stock’s average daily volume over the past 60 days is 39,235 and its 52-week low/high is $0.006/$0.10.

HighCom Global Security, Inc. (HCGS) is a manufacturer and distributor of protective products for military and law enforcement personnel. The Corporation operates under two segments, BlastGard Defense Group and Highcom Security.

BlastGard is a blast mitigation specialist with proprietary material proven to effectively mitigate blasts and suppress fires resulting from explosions. The company's patented BlastWrap® technology acts as a "virtual tent" to effectively mitigate blast effects and suppress post-blast fires. This unique technology works by triggering physical and chemical processes to dissipate blast energy, thereby reducing the aftermath of acoustic and shock waves, peak overpressure, reflected peak overpressure, impulse and afterburn. The remaining, significantly reduced energy is transmitted at a slower, more sustainable level. Notably, BlastWrap does not dispense chemical extinguishants; uses neither alarms, sensors, nor an activation system; and is nontoxic and ecologically friendly.

Similarly, the company's BlastGard MTR trash receptacles dramatically reduce lethal threats posed by the detonation of an improvised explosive device (IED). Equipped with Triple Wall Technology, BlastGard MTR mitigates primary fragments, secondary fragments, mechanical effects (shock/blast pressure) and thermal effects (contact and radiation burn) from the fireball, after-burn and resultant post-blast fires.

BlastGard's primary market focus lies on providing blast effects mitigation solutions for customers operating in the commercial sector, military, law enforcement and government agencies. With a vision of being recognized as the leading provider of environmentally responsible solutions to protect lives and structures from the hazards associated with fire and explosions, the company is capable of addressing a wide array of industry applications spanning from fire suppression for naval vessels and merchant ships to protection of buildings against vehicle bombs.

This vision is supported by the ban of Halon extinguishing agents, as outlined in the Montreal protocol, which effectively establishes BlastWrap® as the only blast and fire suppression means available for most applications, including adaptation for underwater use.

The company's position at the head of the blast suppression market has helped BlastGard attain a number of government awards, including designation of its BlastWrap® product as a Qualified Anti-Terrorism Technology and placement on the "Approved Products List for Homeland Security." This designation was extended in early 2017, meaning that BlastWrap® is approved for use by the Department of Homeland Security under the SAFETY Act until November 2021.

HighCom Security, develops, tests, manufactures and distributes body armor and personal protective equipment, including more than two dozen NIJ (National Institute of Justice) compliant hard and soft armor products. Highcom Security has a 20-year history of producing quality armor with no operational failures and no recalls of its American made products.

Highcom Security was founded in 1997 and has produced close to 1 million pieces of armor for the Global community. The company is ISO 9001:2008 certified and the first company in the world to be BA 9000:2012 certified compliant.

For the past decade, Highcom Security has also been able to offer some of the largest armor manufacturers with private label/OEM hard armor solutions for end use by military and law enforcement agencies globally, a market reach obtained because of the company's reputation for innovative technology, exceptional customer service and superior quality performance. Disclaimer

HighCom Global Security, Inc. Blog

HighCom Global Security, Inc. News:

HighCom Global Security Provides Q2, FH 2017 Financial Update

HighCom Global Security Issues Update on Product Technology Advances

HighCom Global Security Introduces New CEO and Board of Directors as Part of Globally Focused Restructuring Plan


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



(PRZM) +35.71%


Wall Street Mover
(BONT) +32.91%


Trader Power News
(TYHT) +30.94%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251